Literature DB >> 6403619

gamma Interferon production appears to predict time of recurrence of herpes labialis.

A L Cunningham, T C Merigan.   

Abstract

Peripheral blood mononuclear cells separated from the blood of 29 volunteers within 3 wk of the onset of recurrent oral herpes labialis spontaneously secreted IFN-gamma (and small amounts of IFN-beta) into the culture medium in varying amounts (mean = 77 U/ml, SE = 17). However, interferon could not be detected in the serum of 10 of these patients tested. In the group as a whole, peak levels of interferon were secreted in vitro at 6 to 20 days after the onset of herpes labialis. Serial studies in eight patients showed peak production in the second or third week, with subsequent decrease to undetectable levels at 6 wk. A strong correlation between peak supernatant interferon level and the time to the next recurrence of herpes labialis in each patient was noted (r = 0.82, p less than 0.0001). Herpes simplex antigen-stimulated mononuclear cell cultures from each patient produced a mixture of IFN-alpha and IFN-gamma. A less marked but still significant correlation was noted between the peak mixed interferon level and the inter-recurrence interval (r = 0.52, p less than 0.005). These results suggest that a recurrent herpes labialis acts as an in vivo stimulus to the induction of IFN-gamma-producing cells that circulate in peripheral blood. The IFN-gamma produced is either a direct determinant of frequency of recurrence of herpes or a quantitative marker for other cellular immune events determining frequency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403619

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.

Authors:  J P Christensen; R D Cardin; K C Branum; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.

Authors:  Christopher M Hull; Myron J Levin; Stephen K Tyring; Spotswood L Spruance
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

3.  Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs.

Authors:  R J Ho; R L Burke; T C Merigan
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Interferon-Gamma Enhances TLR3 Expression and Anti-Viral Activity in Keratinocytes.

Authors:  A I Kajita; Shin Morizane; Tetsuya Takiguchi; Takenobu Yamamoto; Masao Yamada; Keiji Iwatsuki
Journal:  J Invest Dermatol       Date:  2015-03-30       Impact factor: 8.551

5.  Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission.

Authors:  Z Mikloska; A L Cunningham
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Evolution of recurrent herpes simplex lesions. An immunohistologic study.

Authors:  A L Cunningham; R R Turner; A C Miller; M F Para; T C Merigan
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

7.  Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.

Authors:  A Weinberg; M Konrad; T C Merigan
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

8.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.

Authors:  David M Koelle; Amalia Magaret; Christopher L McClurkan; Michael L Remington; Terri Warren; Florentina Teofilovici; Anna Wald
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

10.  Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis.

Authors:  C G Kallenberg; B M Schilizzi; F Beaumont; L De Leij; S Poppema; T H The
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.